(Q38966352)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

meta-analysis

0 references

title

Hepatitis B immunoglobulin during pregnancy for prevention of mother-to-child transmission of hepatitis B virus (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

0 references

1 reference

1 reference

Ahizechukwu C Eke

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

George U Eleje

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Uzoamaka A Eke

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Yun Xia

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

Jiao Liu

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

publication date

11 February 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

2 April 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

volume

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

page(s)

CD008545

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

Interruption of HBV intrauterine transmission: a clinical study

2 April 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Effect of hepatitis B immunoglobulin on interruption of HBV intrauterine infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

A randomized controlled clinical trial: interruption of intrauterine transmission of hepatitis B virus infection with HBIG.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Evaluation of prophylaxis against hepatitis B in a large municipal hospital

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B virus infection in general population in Madagascar: evidence for different epidemiological patterns in urban and in rural areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Prevalence of hepatitis B virus infection in the Austral archipelago, French Polynesia: identification of transmission patterns for the formulation of immunization strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Prevention of perinatal transmission of hepatitis B virus: a comparison between the efficacy of passive and passive-active immunization in Korea

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Screening of pregnant women for hepatitis B markers in a French Provincial University Hospital (Limoges) during 15 years

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

British HIV Association and Children's HIV Association guidelines for the management of HIV infection in pregnant women 2008

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Epidemiological patterns of hepatitis B virus (HBV) in highly endemic areas

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Immunoprophylaxis of perinatal transmission of the hepatitis B virus: efficacy of hepatitis B immune globulin and hepatitis B vaccine in a low-prevalence area

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B and pregnancy: an underestimated issue

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Transmission of hepatitis B virus infection in Ethiopia with emphasis on the importance of vertical transmission

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Lamivudine in late pregnancy to prevent perinatal transmission of hepatitis B virus infection: a multicentre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Combination low-dose hepatitis B immune globulin and lamivudine therapy provides effective prophylaxis against posttransplantation hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Short duration of lamivudine for the prevention of hepatitis B virus transmission in pregnancy: lack of potency and selection of resistance mutations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Australia Antigen and the Biology of Hepatitis B

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Antiviral therapy in chronic hepatitis B viral infection during pregnancy: A systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Cost effectiveness of first-line oral antiviral therapies for chronic hepatitis B : a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Efficacy and safety of tenofovir disoproxil fumarate in pregnancy for the prevention of vertical transmission of HBV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Methods for combining randomized clinical trials: strengths and limitations.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Meta-analysis in clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Prevalence, correlates and pattern of hepatitis B surface antigen in a low resource setting

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Adverse reactions following administration of human gamma globulin.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Prevention of mother-to-child transmission of hepatitis B virus and hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Risk factors of HBV intrauterine transmission among HBsAg-positive pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

What is "quality of evidence" and why is it important to clinicians?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

GRADE guidelines: 8. Rating the quality of evidence--indirectness

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B immune globulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B e antigen-negative chronic hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

A prospective and open-label study for the efficacy and safety of telbivudine in pregnancy for the prevention of perinatal transmission of hepatitis B virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Thresholds for statistical and clinical significance in systematic reviews with meta-analytic methods

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Immunization interventions to interrupt hepatitis B virus mother-to-child transmission: a meta-analysis of randomized controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Reported methodologic quality and discrepancies between large and small randomized trials in meta-analyses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B immunisation for newborn infants of hepatitis B surface antigen-positive mothers

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Factors associated with mother-to-child transmission of hepatitis B virus despite immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Industry sponsorship and research outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Mother-to-child transmission of HBV: review of current clinical management and prevention strategies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B immunisation in persons not previously exposed to hepatitis B or with unknown exposure status

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Does quality of reports of randomised trials affect estimates of intervention efficacy reported in meta-analyses?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Epidemiology and Reporting Characteristics of Systematic Reviews of Biomedical Research: A Cross-Sectional Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Tenofovir disoproxil fumarate for prevention of vertical transmission of hepatitis B virus infection by highly viremic pregnant women: a case series

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Comparison of two methods to detect publication bias in meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B virus and hepatitis C virus in pregnant Sudanese women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Chronic hepatitis B: current and future treatment options

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Literature searching for randomized controlled trials used in Cochrane reviews: rapid versus exhaustive searches

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B vaccination during pregnancy for preventing infant infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Influence of reported study design characteristics on intervention effect estimates from randomised controlled trials: combined analysis of meta-epidemiological studies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Outcomes of infants born to women infected with hepatitis B.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Lamivudine in late pregnancy to interrupt in utero transmission of hepatitis B virus: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Hepatitis B immunoglobulin injection in pregnancy to interrupt hepatitis B virus mother-to-child transmission-a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Passive-active immunisation against hepatitis B: immunogenicity studies in adult Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Use of tenofovir disoproxil fumarate in highly viremic, hepatitis B mono-infected pregnant women

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Managing HBV in pregnancy. Prevention, prophylaxis, treatment and follow-up: position paper produced by Australian, UK and New Zealand key opinion leaders

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Estimating required information size by quantifying diversity in random-effects model meta-analyses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Risk factors and mechanism of transplacental transmission of hepatitis B virus: a case-control study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Measures to reduce mother-to-child transmission of Hepatitis B virus in China: a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Management of mother-to-child transmission of hepatitis B virus: Propositions and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

Identification of risk factors associated with immunoprophylaxis failure to prevent the vertical transmission of hepatitis B virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008545.PUB2

A preliminary study on interruption of HBV transmission in uterus

21 January 2018

1 reference

12 December 2020

Hepatitis B in pregnancy

1 reference

12 December 2020

Evaluation and management of hepatitis B in pregnancy: a survey of current practices

1 reference

12 December 2020

Vertical transmission of hepatitis B virus: challenges and solutions

1 reference

12 December 2020

Efficacy of Hepatitis B Immune Globulin for Prevention of Perinatal Transmission of the Hepatitis B Virus Carrier State: Final Report of a Randomized Double-Blind, Placebo-Controlled Trial

1 reference

12 December 2020

Hepatitis B immune globulin (HBIG) efficacy in the interruption of perinatal transmission of hepatitis B virus carrier state. Initial report of a randomised double-blind placebo-controlled trial.

1 reference

12 December 2020

The role of placenta in hepatitis B virus intrauterine transmission

1 reference

12 December 2020

Recommendations for identification and public health management of persons with chronic hepatitis B virus infection

1 reference

12 December 2020

Knowledge of obstetricians about the vertical transmission of hepatitis B virus

1 reference

12 December 2020

Immunogenicity and safety of two schedules of Hepatitis B vaccination during pregnancy

1 reference

12 December 2020

Telbivudine during the second and third trimester of pregnancy interrupts HBV intrauterine transmission: a systematic review and meta-analysis

1 reference

12 December 2020

Prevention of hepatitis B virus transmission by immunization. An economic analysis of current recommendations

1 reference

12 December 2020

Mechanism of intrauterine infection of hepatitis B virus.

1 reference

12 December 2020

Prevention of perinatal acquisition of hepatitis B virus carriage using vaccine: preliminary report of a randomized, double-blind placebo-controlled and comparative trial.

1 reference

12 December 2020

Passive immunization for hepatitis B.

1 reference

12 December 2020

Hepatitis B in pregnancy

1 reference

12 December 2020

Prevention of hepatitis B virus infection in children born to HBsAg positive/HBeAg positive mothers. Preliminary results of active and passive-active immunization

1 reference

12 December 2020

Hepatitis B surface antigen prevalence among pregnant women in urban areas: implications for testing, reporting, and preventing perinatal transmission

1 reference

12 December 2020

A randomized controlled trial on effect of hepatitis B immune globulin in preventing hepatitis B virus transmission from mothers to infants

1 reference

12 December 2020

[The impact of antepartum injection of hepatitis B immunoglobulin on maternal serum HBV DNA and anti-HBs in the newborns]

1 reference

12 December 2020

Sytematic review and meta-analysis of prevalence of hepatitis B in India.

1 reference

12 December 2020

Antepartum immunoprophylaxis of three doses of hepatitis B immunoglobulin is not effective: a single-centre randomized study

1 reference

12 December 2020

A randomized control trial on interruption of HBV transmission in uterus

1 reference

12 December 2020

Prevention of intrauterine infection by hepatitis B virus with hepatitis B immune globulin: efficacy and mechanism

1 reference

12 December 2020

Perinatal transmission of hepatitis B virus: an Australian experience

1 reference

12 December 2020

A comparison between the efficacy of passive-active and active immunization for prevention of perinatal transmission of hepatitis B virus

1 reference

12 December 2020

Efficacy of hepatitis B immune globulin in prevention of perinatal transmission of the hepatitis B virus.

1 reference

12 December 2020

Hepatitis B in pregnancy: a concise review of neonatal vertical transmission and antiviral prophylaxis

1 reference

12 December 2020

Combined passive and active immunization for interruption of perinatal transmission of hepatitis B virus in Taiwan

1 reference

12 December 2020

Perinatal HBV viremia in newborns of HBsAg(+) mothers is a transient phenomenon that does not necessarily imply HBV infection transmission

1 reference

12 December 2020

Failure of neonatal hepatitis B vaccination: the role of HBV-DNA levels in hepatitis B carrier mothers and HLA antigens in neonates

1 reference

12 December 2020

Significance of isolated hepatitis B core antibody in blood donors from São Paulo

1 reference

12 December 2020

10.1002/14651858.CD008545.PUB2

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28188612%20AND%20SRC:MED&resulttype=core&format=json

2 April 2020

PubMed publication ID

28188612

1 reference